Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer [Phase 1]

View source ↗

Summary

The update announces a Phase 1 trial of HRS-1358 tablets for metastatic or locally advanced breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-1358 (HRS-1358)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING